National Health Investors (NYSE:NHI) Stock Rating Lowered by Wells Fargo & Company

Wells Fargo & Company cut shares of National Health Investors (NYSE:NHI – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday, Marketbeat Ratings reports. The brokerage currently has $86.00 target price on the real estate investment trust’s stock, up from their prior target price of $81.00. Other […]

Leave a Reply

Your email address will not be published.

Previous post Week 5 high school football preview: Malden Catholic has arrived
Next post Hologic (NASDAQ:HOLX) Cut to “Neutral” at Citigroup